Paraneoplastic Polymyositis – a Case Report

Česká verzia

Authors: J. Latta ¹; J. Zámečník ²; E. Ehler ¹
Authors place of work: Neurologická klinika FZS UP a Pardubická krajská nemocnice, a. s ¹; Ústav patologie a molekulární medicíny, 2. LF UK a FN v Motole, Praha ²
Published in the journal: Cesk Slov Neurol N 2012; 75/108(1): 80-83
Category: Case Report

Summary

Clinical findings, biochemical results and EMG investigation are important in the diagnosis of myopathy, and muscle biopsy is unavoidable for its further differentiation. In an older man with muscle pain and rapid development of muscle weakness with head-drop and dysphagia, polymyositis with focal endomysial CD8+ lymphocytic infiltrates was diagnosed on muscle biopsy. Once the patient had been hospitalized, an advanced carcinoma of the prostate and anti-Ri paraneoplastic antibodies were found. A paraneoplastic polymyositis was diagnosed, which is a rare diagnosis in patients with prostate cancer.

Key words:
dysphagia – neck muscles weakness – EMG – creatinkinase – muscle biopsy – paraneoplastic polymyositis

Zdroje

1. Pelosof LC, Gerber DE. Paraneoplastic syndromes: an approach to diagnosis and treatment. Mayo Clin Proc 2010; 85(9): 838–854.

2. Posner JB. Paraneoplastic syndromes. Neurologic Clinics 1991; 9(4): 919–936.

3. Darnell RB, Posner JB. Paraneoplastic syndromes involving the nervous system. New Engl J Med 2003; 349(16): 1543–1554.

4. Amato AA, Russel JA. Neuromuscular disorders. New York: McGraw Hill Medical 2007.

5. Minisini AM, Pauletto G., Bergonzi P, Fasola G. Paraneoplastic neurological syndrome and breast cancer. Regression of paraneoplastic neurological sensorimotor neuropathy in a patient with metastatic breast cancer treated with capecitabine: a case study and mini-review of the literature. Breast Cancer Res Treat 2007; 105(2): 133–138.

6. Mowzoon N, Flemming KD. Neurology board review: an illustrated study guide. Rochester: Mayo Clinic Scientific Press 2007.

7. Amato AA, Greenberg SD. Inflammatory myopathies. Continuum 2006; 12(3): 140–168.

8. Bednařík J et al. Nemoci kosterního svalstva. Praha: Triton 2001.

9. Dalakas MC, Karpati G. Inflammatory myopathies. In: Karpati G, Hilton-Jones D, Bushby K, Griggs RC (eds). Disorders of voluntary muscles. 8th ed. Cambridge: Cambridge University Press 2010, 427–452.

10. Hong MK, Kong J, Namdarian B, Longano A, Grummet J, Hovens CM et al. Paraneoplastic syndromes in prostate cancer. Nat Rev Urol 2010; 7(12): 681–692.

11. Crayton H, Bohlmann T, Sufit R, Graziano FM. Drµg induced polymyositis secondary do leuprolide acetate (Lupron) therapy for prostate carcinoma. Clin Exp Rheumatol 1991; 9(5): 515–528.

12. Nakanishi S, Hatayama T. Adenocarcinoma of the prostate associated with anti Jo-1 antibody positive polymyositis. Hinyokika Kiyo 2006; 52(4): 289–191.

13. Park Y, Oster MW, Olarte MR. Prostatic cancer with an unusual presentation: polymyositis and mediastinal adenopathy. Cancer 1981; 48(5): 1262–1264.

14. Tembe AG, Ramteke S, Joshi VR, Balakrishnan C. Dermatomyositis/polymyositis associated with malignancy: our experience with ten patients and review of relevant literature. Internat J Rheum Dis 2008; 11(3): 269–273.

15. Dalakas MC. The future prospects in the classification, diagnosis and therapies of inflammatory myopathies: a view to the future from the “bench-to-bedside”. J Neurol 2004; 251(6): 651–657.

16. Levin MI, Mozaffar T, Al-Lozi MT, Pestronk A. Paraneoplastic necrotizing myopathy. Clinical and pathologic features. Neurology 1998; 50(3): 764–767.

17. Suber TL, Casciola-Rosen L, Rosen A. Mechanisms of disease: autoantigens as clues to the pathogenesis of myositis. Nat Clin Pract Rheumatol 2008; 4(4): 201–209.

18. Dankó K, Ponyi A, Molnar AP, András C, Constantin T. Paraneoplastic myopathy. Curr Opin Rheumatol 2009; 21(6): 594–598.

19. Oh SJ. Clinical electromyography. Case studies. Baltimore: Williams & Wilkins 1998.

20. Pourmand R. Immune-mediated neuromuscular diseases. Basel: Karger 2009.

21. Brown WF, Bolton CF, Aminoff MJ. Neuromuscular function and disease. Philadelphia: W.B. Saunders Company 2002.

22. Hewer E, Goebel HH. Myopathology of non-infectious inflammatory myopathies – the current status. Pathol Res Pract 2008; 204(9): 609–623.